Seaport Therapeutics, Inc. (SPTX)
Seaport Therapeutics, Inc. (SPTX) is a Healthcare stock tracked by StreetAlpha. It last closed at $18.05 on Nov 20, down 1.47% on the day. The next earnings report for SPTX is expected around Mon, Feb 1, 2027. Over its last 3 reports the stock moved an average of 1.5% the session after earnings. Over the last 12 months SPTX insiders bought $20.1M of stock on the open market and sold $0, according to SEC Form 4 filings.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →- Every upgrade, downgrade and initiation as it happens
- Every price target change, raised or cut
- Consensus rating with the average, high and low targets
- Each firm's full rating history on SPTX
Technical AnalysisPrices may be delayed
The stock is 12% below its 20 day and 10% below its 50 day average. Momentum is weak (RSI 39). The nearest support is the swing low (Jul 8) at $17.89, and the nearest resistance the Pivot at $18.10.
| RSI (14) | 38.55 | Weak, oversold below 30 | Neutral |
| MACD | -0.40 | Below its signal line | Bearish |
| Stochastic | 12.3 | Near the bottom of its range | Oversold |
| ADX (14) | 15.6 | No clear trend | |
| Williams %R | -87.9 | Oversold below −80, overbought above −20 | Oversold |
| CCI (20) | -154.0 | Oversold below −100, overbought above 100 | Oversold |
| Rate of change | −16.1% | Change over 10 sessions | Bearish |
| ATR (14) | $1.49 | Typical daily range, 8.2% of price |
| RSI (14) | 43.15 | Middle of its range | Neutral |
| MACD | -0.09 | ||
| Stochastic | 32.2 | Middle of its range | Neutral |
| ADX (14) | 11.0 | No clear trend | |
| Williams %R | -82.0 | Oversold below −80, overbought above −20 | Oversold |
| CCI (20) | -101.5 | Oversold below −100, overbought above 100 | Oversold |
| Rate of change | −22.7% | Change over 10 sessions | Bearish |
| ATR (14) | $3.14 | Typical daily range, 17.4% of price |
What happened before
See how SPTX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Whale Options FlowPrices may be delayed
90DNo whale options trades in SPTX in the last 90 days.
Dark PoolPrices may be delayed
30DSPTX Institutional Ownership
Full report →- ▲47 buying vs 19 selling
- ▲Held by funds +1.4 pts
- ▲Funds holding +20
- ●Superinvestors: 1 added, 1 cut
- ●Put/call not meaningful
| Q3 2026 | This quarter | Last quarter | Change |
|---|---|---|---|
| Funds holding | 74 | 54 | +37.0% |
| In funds' top 10 | 5 | 5 | 0.0% |
| Held by funds | 71.3% | 69.9% | +1.4 pts |
| New / increased | 27 / 20 | 54 / 0 | −13.0% |
| Reduced / sold out | 12 / 7 | 0 / 0 | – |
| Put/call ratio | – | – | – |
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
SPTX Insider Trading
All filings →| Trade date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 3 | Denice TorresDirector | Buy | 5,000 | $19.86 | $99K |
| Jun 22 | Robert J. HombachDirector | Buy | 13,000 | $18.14 | $236K |
| May 4 | ARCH Venture Partners XII, LLC10% owner | Buy | 1,100,000 | $18.00 | $19.8M |
From SEC Form 4 filings by SPTX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper tradingStreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SPTX is in one of them and how their past SPTX trades turned out.
SPTX News Tone and PricePrices may be delayed
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered SPTX in an article yet. Here's the latest on the wider market.

